CU6 1.69% $6.38 clarity pharmaceuticals ltd

Ann: Clarity strengthens Cu-64 network with new supply agreement, page-17

  1. 4,625 Posts.
    lightbulb Created with Sketch. 1827
    I think it's important to emphasise that whilst TLX, with a market cap of $5+ billion, has already got an established and highly profitable business in the very same radiopharmaceutical treatment of patients with prostate cancer.

    This new "upstart" Clarity, with a market cap now approaching A$1 billion, has become a very serious threat to Telix through what appears to be a best-in-class imaging and therapy via its Cu64/Cu67 radioligand.

    And Clarity's platform clearly has the potential to extend way beyond prostate cancer over time.

    I'd certainly be worried if I was the CEO of TLX.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$6.38
Change
-0.110(1.69%)
Mkt cap ! $1.988B
Open High Low Value Volume
$6.30 $6.46 $6.30 $6.417M 1.006M

Buyers (Bids)

No. Vol. Price($)
2 3583 $6.35
 

Sellers (Offers)

Price($) Vol. No.
$6.40 16377 1
View Market Depth
Last trade - 16.10pm 30/07/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.